Useful as a reference for all who work in nuclear medicine and radiology, this reference introduces issues relating to the production and application of radiopharmaceuticals. Coverage encompasses the production of various radionuclides, positron emission tomography, drug development, and the use of radiopharmaceuticals in cancer therapy. Editor Welch is affiliated with the Washington University School of Medicine; Redvanly, with the chemistry department at Brookhaven National Laboratory Associated Universities Ltd. Annotation (c) Book News, Inc., Portland, OR (booknews.com)
A comprehensive, authoritative and up-to-date reference for the newcomer to radiopharmaceuticals and those already in the field.
Radiopharmaceuticals are used to detect and characterise disease processes, or normal biological function, in living cells, animals or humans. Used as tracer molecules, they map the distribution, uptake and metabolism of the molecule in clinical studies, basic research or applied research.
The area of radiopharmaceuticals is expanding rapidly. The number of PET centers in the world is increasing at 20% per year, and many drug companies are utilising PET and other forms of
radiopharmaceutical imaging to evaluate products.
* Readers will find coverage on a number of important topics such as radionuclide production, PET and drug development, and regulations
* Explains how to use radiopharmaceuticals for the diagnosis and therapy of cancer and other diseases
* The editors and a majority of the contributors are from the United States
